Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence

Journal of Clinical Oncology

Volumn 18, Issue 12, 2000, Pages 2435-2443

  Metayer, Catherine ^a   Lynch, Charles F ^a   Clarke, E Aileen ^a   Glimelius, Bengt ^a   Storm, Hans ^a   Pukkala, Eero ^a   Joensuu, Timo ^a   Van Leeuwen, Flora E ^a   Van't Veer, Mars B ^a   Curtis, Rochelle E ^a   Holowaty, Eric J ^a   Andersson, Michael ^a   Wiklund, Tom ^a   Gospodarowicz, Mary ^a   Travis, Lois B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; DIGESTIVE SYSTEM CANCER; FEMALE; HODGKIN DISEASE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SECOND CANCER; SEX DIFFERENCE; SOLID TUMOR; THYROID CANCER;

EID: 0034088026     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.12.2435     Document Type: Article

References (60)

1. DeVita VT Jr, Serpick AA, Carbone PP: Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 73:881-895, 1970
2. DeVita VT Jr, Mauch P, Lee Harris N: Hodgkin's disease, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology (ed 5). Philadelphia, PA, Lippincott, 1997, pp 2242-2277
3. Hunger SP, Link MP, Donaldson SS: ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: The Stanford experience. J Clin Oncol 12:2160-2166, 1994
4. Rock DB, Murray KJ, Schultz CJ, et al: Stage I and II Hodgkin's disease in the pediatric population: Long-term follow-up of patients staged predominantly clinically. Am J Clin Oncol 19:174-178, 1996
5. Bhatia S, Robison LL, Oberlin O, et al: Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334:745-751, 1996
6. Sankila R, Garwicz JH, Olsen J, et al: Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five Nordic countries. J Clin Oncol 14:1442-1446, 1996
7. Wolden SL, Lamborn KR, Cleary SF, et al: Second cancers following pediatric Hodgkin's disease. J Clin Oncol 16:536-544, 1998
8. Jenkin D, Greenberg M, Fitzgerald A: Second malignant tumours in childhood Hodgkin's disease. Med Ped Oncol 26:373-379, 1996
9. Mauch PM, Kalish LA, Marcus KC, et al: Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: Long-term analysis of risk factors and outcome. Blood 87:3625-3632, 1996
10. Swerdlow AJ, Barber JA, Horwich A, et al: Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. Br J Cancer 75:116-123, 1997
11. Beaty O, Hudson MM, Greenwald C, et al: Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 13:603-609, 1995
12. Tarbell NJ, Gelder RD, Weinstein HJ, et al: Sex-difference in risk of second malignant tumors after Hodgkin's disease in childhood. Lancet 341:1428-1432, 1993
13. Hancock SL, Tucker MA, Hoppe RT: Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85:25-31, 1993
14. Meadows AT, Obringer AC, Marrero O, et al: Second malignant neoplasms following childhood Hodgkin's disease: Treatment and splenectomy as risk factors. Med Ped Oncol 17:477-484, 1989
15. Kushner BH, Zauber A, Tan CTC: Second malignancies after childhood Hodgkin's disease: The Memorial Sloan-Kettering Cancer Center Experience. Cancer 62:1364-1370, 1988
16. Green DM, Lee RJ, Barcos M, et al: Second malignant neoplasms after treatment for Hodgkin's disease in childhood and adolescence. Proc Am Assoc Cancer Res 39:504, 1998 (abstr 3430)
17. van Leeuwen FE, Klokman WJ, van't Veer MB, et al: Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence and young adulthood. J Clin Oncol 18:487-497, 2000
18. Swerdlow AJ, Barber JA, Vaughan Hudson G, et al: Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment. J Clin Oncol 18:498-509, 2000
19. Donaldson SS, Link MP: Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease. J Clin Oncol 5:742-749, 1987
20. Robinson B, Kingston J, Costa RN, et al: Chemotherapy and irradiation in childhood Hodgkin's disease. Arc Dis Child 59:1162-1167, 1984
21. Leventhal BG, Donaldson SS: Hodgkin's disease, in Pizzo PA, Poplack DG (eds): Principle and Practice of Pediatric Oncology (ed 4). Philadelphia, PA, Lippincott, 1993, pp 584-590
22. Parkin DM, Whelan SL, Ferlay J, et al: Cancer Incidence in Five Continents, Vol VII, No. 143. Lyon, France, International Agency for Research on Cancer, 1997
23. World Health Organization: International Classification of Diseases for Oncology (ed 1). Geneva, Switzerland, World Health Organization, 1976
24. Breslow NE, Lubin JH, Marek P, et al: Multiplicative models and cohort analysis. J Am Stat Assoc 78:1-12, 1983
25. Cutler SJ, Ederer F: Maximum utilization of the life table method in analyzing survival. J Chronic Dis 8:699-712, 1958
26. van Leeuwen FE, Klokman WJ, Hagenbeek A, et al: Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol 12:312-325, 1994
27. Henry-Amar M: Second cancer after the treatment for Hodgkin's disease: A report from the International Database on Hodgkin's disease. Ann Oncol 3:117-128, 1992 (suppl 4)
28. Swerdlow AJ, Douglas AJ, Vaughan Hudson G, et al: Risk of second primary cancers after Hodgkin's disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma investigation. Br Med J 304:1137-1143, 1992
29. Boivin JF, Hutchison GB, Zauber AG, et al: Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 87:732-741, 1995
30. Tucker MA, Coleman CN, Cox RS, et al: Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 318:76-81, 1988
31. Thompson DE, Mabuchi K, Ron E, et al: Cancer incidence in atomic bomb survivors: Part II. Solid tumors, 1958-1987. Radiat Res 137:S17-S67, 1994
32. Ron E, Lubin JH, Shore RE, et al: Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies. Radiat Res 141:259-277, 1995
33. Schneider AB, Lubin J, Ron E, et al: Salivary gland tumors after childhood radiation treatment for benign conditions of the head and neck: Dose-response relationships. Radiat Res 149:625-630, 1998
34. Spitz MR, Fueger JJ, Goepfert H, et al: Salivary gland cancer: A case-control investigation of risk factors. Arc Otolaryngol Head Neck Surg 116:1163-1166, 1990
35. Land CE, Saku T, Hayashi Y, et al: Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987: Evaluation of radiation-related risk. Radiat Res 146:28-36, 1996
36. van Leeuwen FE, Klokman WJ, Stovall M, et al: Role of radiotherapy and smoking in lung cancer following Hodgkin's disease. J Natl Cancer Inst 87:1530-1537, 1995
37. Kaldor JM, Day NE, Bell J, et al: Lung cancer following Hodgkin's disease: A case-control study. Int J Cancer 52:677-681, 1992
38. Boice JD Jr, Land EC, Preston DL: Ionizing radiation, in Schottenfeld D, Fraumeni JF Jr (eds): Cancer Epidemiology and Prevention (ed 2). New York, NY, Oxford University Press, 1996, pp 319-354
39. Kim R, Weissfeld JL, Reynolds JC, et al: Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 6:369-377, 1997
40. Lagergren J, Bergstrom R, Lindgren A, et al: Symptomatic gastrointestinal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825-831, 1999
41. Dahms BB, Greco MA, Strandjord SE, et al: Barrett's esophagus in three children after antileukemia chemotherapy. Cancer 60:2896-2900, 1987
42. Sartori S, Nielsen I, Indelli M, et al: Barrett esophagus after chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF): An iatrogenic injury? Ann Int Med 114:210-211, 1991
43. Chow WH, Blot WJ, Vaughan TL, et al: Body mass index and risk of adenocarcinoma of the esophagus and gastric cardia. J Natl Cancer Inst 90:150-155, 1998
44. Poljak M, Cerara A, Seme K: Human papillomavirus infections in esophageal carcinomas: A study of 121 lesions using multiple broad-spectrum polymerase chain reactions and literature review. Hum Pathol 29:266-271, 1998
45. Coleman MP, Bell CMJ, Fraser P: Secondary primary malignancy after Hodgkin's disease, ovarian cancer and cancer of the testis: A population-based cohort study. Br J Cancer 56:349-355, 1987
46. Kaldor JM, Day NE, Band P, et al: Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: An international collaborative study among cancer registries. Int J Cancer 39:571-585, 1987
47. Schiffman MH, Brinton LA: The epidemiology of cervical carcinogenesis. Cancer 76:1888-1901, 1995 (suppl 10)
48. Breitburd F, Ramoz N, Salmon J, et al: HLA control in the progression of human papillomavirus infections. Sem Cancer Biol 7:359-371, 1996
49. Tucker MA, Misfeldt D, Coleman CN, et al: Cutaneous malignant melanoma after Hodgkin's disease. Ann Intern Med 102:37-41, 1985
50. Abrahamsen JF, Andersen A, Hannisdal E, et al: Second malignancies after treatment of Hodgkin's disease: The influence of treatment, follow-up time, and age. J Clin Oncol 11:255-261, 1993
51. Baird EA, McHenry PM, MacKie RM: Effect of maintenance chemotherapy in childhood on numbers of melanocytic naevi. Br Med J 305:799-801, 1992
52. Hughes BR, Cunliffe WJ, Bailey CC: Excess benign melanocytic naevi after chemotherapy for malignancy in childhood. Br Med J 299:88-91, 1989
53. Tucker MA, Morris-Jones PH, Boice JD, et al: Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res 51:2885-2888, 1991
54. Lundell M, Mattsson A, Hakulinen T, et al: Breast cancer after radiotherapy for skin hemangioma in infancy. Radiat Res 145:225-230, 1996
55. Tokunaga M, Land CE, Tokuoka S, et al: Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat Res 138:209-223, 1994
56. Aisenberg AC, Finkelstein DM, Doppke KP, et al: High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer 79:1203-1210, 1996
57. Gross PE, Sierra S: Current perspectives on radiation-induced breast cancer. J Clin Oncol 16:338-347, 1998
58. Boice JD Jr, Preston DL, Davis FG, et al: Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res 125:214-222, 1991
59. Birdwell SH, Hancock SL, Varghese A, et al: Gastrointestinal cancer after treatment of Hodgkin's disease. Int J Radiat Oncol Biol Phys 37:67-73, 1997
60. Griem ML, Kleinerman RA, Boice JD Jr, et al: Cancer following radiotherapy for peptic ulcer. J Natl Cancer Inst 86:842-849, 1994